March 4 (Reuters) - Moderna shares rose ⁠9% ⁠on Wednesday after it settled ⁠a long-running legal battle over the technology that made its COVID-19 vaccine possible, removing an overhang and allowing ...

Looking to get a COVID-19 vaccine booster for yourself or your child this fall? It may be a bit more complicated than just making an appointment. In August, the U.S. Food and Drug Administration ...

Many people are running into confusion this season when trying to get a COVID-19 vaccine. That’s because federal guidance changed this fall: vaccine advisers to the U.S. Centers for Disease Control ...

It's officially the season of text prompts and phone call reminders to get your seasonal vaccines. Cases of flu, RSV, COVID-19, and other common respiratory illnesses tend to spike as temperatures go ...

German biotech firm CureVac has taken Moderna to court in Delaware, claiming the American drugmaker’s blockbuster Spikevax COVID-19 vaccine infringes patents on the messenger RNA technology that makes ...

It's an anniversary no one wants to celebrate, but an anniversary nonetheless. Thursday, March 19, marked six years since the first COVID-19 lockdown was implemented in the United States. And while it ...

Most Americans with health insurance should not have to pay out of pocket for Covid-19 vaccines, even after the US Centers for Disease Control and Prevention added an extra hurdle to getting the shot.

Saskatchewan reported 185 new cases of COVID-19 on Saturday and two more deaths from the illness. Of the 185 new cases, 117 were unvaccinated (63 per cent), 65 cases were vaccinated (35 per cent) and ...

Kevin Ma, PhD, discusses new data showing 2024–2025 COVID-19 vaccines reduced hospitalization and severe outcomes. In this Q&A, lead study author Kevin Ma, PhD, an epidemic intelligence service ...